Stocks
Health Care
ctmx
CytomX Therapeutics
NASDAQ: CTMX
+2.07 (+44.12%)
6.745
USD
At close at Mar 16, 20:40 UTC
Income Statement
Revenue
138.10M
Gross Profit
138.10M
Operating Income
25.00M
Pretax Income
28.26M
Net Income
31.87M
EBITDA
37.94M
EBIT
32.09M
Earnings Per Share
0.39
Balance Sheet
Cash & Cash Equivalents
40.49M
Total Debt
11.15M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-21.70M
Book Value Per Share
-0.29
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.